Prasol Chemicals IPO Day 2: Subscription Status and GMP Insights—Is It a Buy?

The Prasol Chemicals IPO has entered Day 2 of its bidding process, with investors having the opportunity to place bids until September 10. As of now, the overall subscription stands at 41% against 54.43 lakh shares on offer. The IPO is a Rs 500 crore book-built issue, which includes a fresh issue of 11.83 lakh shares valued at Rs 80 crore and an offer for sale (OFS) of 62.13 lakh shares worth Rs 420 crore. It is priced within a band of Rs 643-Rs 676 per share, requiring a minimum investment of Rs 14,872 from retail investors, and shares are slated for listing on both the NSE and BSE on September 16, 2026.

In the grey market, the IPO is currently commanding a muted premium of around Rs 30 per share, equivalent to approximately 4% over the upper price band of Rs 676. This suggests subdued expectations regarding listing gains, with the estimated listing price likely at around Rs 706 per share. The grey market activity indicates limited enthusiasm, particularly given that institutional investors have largely remained on the sidelines, with no bids registered from Qualified Institutional Buyers (QIBs) on Day 1.

For Indian investors, the Prasol Chemicals IPO presents a cautiously optimistic scenario. While the company has experienced substantial growth in earnings and possesses a robust product portfolio in the specialty chemicals sector, the current grey market sentiment hints at a conservative outlook for immediate listing gains. Retail investors should weigh these factors alongside the robust fundamentals before making their subscription decisions, particularly in regards to long-term versus short-term investment strategies.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)